Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Research (NRC) Common Equity (2016 - 2025)

Historic Common Equity for National Research (NRC) over the last 16 years, with Q3 2025 value amounting to $14.3 million.

  • National Research's Common Equity fell 5865.75% to $14.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.3 million, marking a year-over-year decrease of 5865.75%. This contributed to the annual value of $31.3 million for FY2024, which is 3609.64% down from last year.
  • National Research's Common Equity amounted to $14.3 million in Q3 2025, which was down 5865.75% from $21.3 million recorded in Q2 2025.
  • In the past 5 years, National Research's Common Equity ranged from a high of $85.3 million in Q4 2021 and a low of $14.3 million during Q3 2025
  • Moreover, its 5-year median value for Common Equity was $67.8 million (2022), whereas its average is $56.6 million.
  • Per our database at Business Quant, National Research's Common Equity surged by 9639.65% in 2021 and then tumbled by 5865.75% in 2025.
  • National Research's Common Equity (Quarter) stood at $85.3 million in 2021, then fell by 15.59% to $72.0 million in 2022, then plummeted by 32.04% to $49.0 million in 2023, then tumbled by 36.1% to $31.3 million in 2024, then tumbled by 54.24% to $14.3 million in 2025.
  • Its Common Equity stands at $14.3 million for Q3 2025, versus $21.3 million for Q2 2025 and $29.7 million for Q1 2025.